We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
In patients with clinically suspected mild endometriosis who have acceptable sperm quality, ovarian stimulation with clomiphene citrate and intrauterine insemination (IUI) for three to four cycles can be utilized for first line treatment. This chapter reviews options including observation, ovarian suppression, ovarian stimulation, surgery, and assisted reproductive technologies. The role of surgery in the treatment of endometriosis has historically been controversial. The first randomized controlled trial (RCT) that addressed the question of whether laparoscopic ablation of endometrial implants and adhesiolysis in patients with early stage endometriosis showed that treatment improved fertility compared to diagnostic laparoscopy alone. Although it is generally accepted that in vitro fertilization (IVF) improves pregnancy rates (PR) in patients with endometriosis versus expectant management, definitive data confirming this is available only from one small RCT. In patients with endometriosis, treatment with GnRHa for 3-6 months prior to IVF cycle start appears to increase ongoing PRs.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.